Aytu Biopharma Inc
AYTU2.290USD
-0.100-4.18%
收盘 02/09, 16:00（美东）报价延迟15分钟
0.94总市值
亏损市盈率 TTM
关于 Aytu Biopharma Inc 公司
Aytu BioPharma, Inc. is a pharmaceutical company focused on commercializing novel therapeutics. The Company's business is focused on its prescription pharmaceutical products sold primarily through third party wholesalers and pharmacies and which primarily consists of two product portfolios. The first consists of two products for the treatment of ADHD: Adzenys XR-ODT (amphetamine) extended-release orally disintegrating tablets (Adzenys) and Cotempla XR-ODT (methylphenidate) extended-release orally disintegrating tablets. The second consists primarily of Karbinal ER (carbinoxamine maleate extended-release oral suspension), an extended-release first-generation antihistamine suspension containing carbinoxamine indicated to treat numerous allergic conditions, and Poly-Vi-Flor and Tri-Vi-Flor, two complementary prescription fluoride-based supplement product lines containing combinations of fluoride and vitamins in various formulations for infants and children with fluoride deficiency.
Aytu Biopharma Inc简介
公司代码AYTU
公司名称Aytu Biopharma Inc
上市日期Oct 20, 2017
CEODisbrow (Joshua R)
员工数量82
证券类型Ordinary Share
年结日Oct 20
公司地址7900 E. Union Avenue
城市DENVER
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编80237
电话17204376580
网址https://aytubio.com/
公司代码AYTU
上市日期Oct 20, 2017
CEODisbrow (Joshua R)
Aytu Biopharma Inc公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Jarrett T. (Josh) Disbrow
Mr. Jarrett T. (Josh) Disbrow
Chief Business Officer
Chief Business Officer
61.57K
+32106.00%
Mr. Ryan J. Selhorn, CPA
Mr. Ryan J. Selhorn, CPA
Chief Financial Officer, Treasurer, Corporate Secretary
Chief Financial Officer, Treasurer, Corporate Secretary
49.74K
+33743.00%
Mr. Greg Pyszczymuka
Mr. Greg Pyszczymuka
Chief Commercial Officer
Chief Commercial Officer
36.10K
+12291.00%
Mr. Carl C. Dockery
Mr. Carl C. Dockery
Independent Director
Independent Director
21.15K
+10000.00%
Ms. Vivian H. Liu
Ms. Vivian H. Liu
Independent Director
Independent Director
19.82K
+10000.00%
Mr. Joshua R. (Josh) Disbrow
Mr. Joshua R. (Josh) Disbrow
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. John A. Donofrio, Jr.
Mr. John A. Donofrio, Jr.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Abhinav (Abi) Jian
Mr. Abhinav (Abi) Jian
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Jarrett T. (Josh) Disbrow
Mr. Jarrett T. (Josh) Disbrow
Chief Business Officer
Chief Business Officer
61.57K
+32106.00%
Mr. Ryan J. Selhorn, CPA
Mr. Ryan J. Selhorn, CPA
Chief Financial Officer, Treasurer, Corporate Secretary
Chief Financial Officer, Treasurer, Corporate Secretary
49.74K
+33743.00%
Mr. Greg Pyszczymuka
Mr. Greg Pyszczymuka
Chief Commercial Officer
Chief Commercial Officer
36.10K
+12291.00%
Mr. Carl C. Dockery
Mr. Carl C. Dockery
Independent Director
Independent Director
21.15K
+10000.00%
Ms. Vivian H. Liu
Ms. Vivian H. Liu
Independent Director
Independent Director
19.82K
+10000.00%
Mr. Joshua R. (Josh) Disbrow
Mr. Joshua R. (Josh) Disbrow
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
收入明细
单位: USD更新时间: 1月6日 周二
单位: USD更新时间: 1月6日 周二
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
ADHD portfolio
13.16M
94.73%
Pediatric portfolio
715.00K
5.15%
Other
17.00K
0.12%
由于公司未披露，未能获取相关数据
业务
地区
业务USD
名称
营收
占比
ADHD portfolio
13.16M
94.73%
Pediatric portfolio
715.00K
5.15%
Other
17.00K
0.12%
股东统计
更新时间: 2月6日 周五
更新时间: 2月6日 周五
持股股东
股东类型
持股股东
持股股东
占比
Nantahala Capital Management, LLC
10.13%
Stonepine Capital Management, LLC
8.31%
AWM Investment Company, Inc.
5.77%
The Vanguard Group, Inc.
2.60%
Diadema Partners LP
2.54%
其他
70.66%
持股股东
持股股东
占比
Nantahala Capital Management, LLC
10.13%
Stonepine Capital Management, LLC
8.31%
AWM Investment Company, Inc.
5.77%
The Vanguard Group, Inc.
2.60%
Diadema Partners LP
2.54%
其他
70.66%
股东类型
持股股东
占比
Investment Advisor/Hedge Fund
15.55%
Hedge Fund
15.19%
Individual Investor
5.13%
Investment Advisor
3.26%
Bank and Trust
0.03%
其他
60.84%
机构持股
更新时间: 12月8日 周一
更新时间: 12月8日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q4
65
3.65M
34.03%
-127.44K
2025Q3
63
3.62M
35.61%
+200.00K
2025Q2
63
3.42M
23.61%
+1.37M
2025Q1
58
1.88M
32.85%
-147.25K
2024Q4
61
1.88M
35.64%
-167.56K
2024Q3
65
2.05M
38.87%
-5.48K
2024Q2
68
2.06M
35.52%
+258.31K
2024Q1
72
1.80M
39.85%
-420.62K
2023Q4
75
1.77M
40.04%
+44.24K
2023Q3
81
1.73M
39.72%
+20.75K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Nantahala Capital Management, LLC
1.09M
10.67%
--
--
Sep 30, 2025
Stonepine Capital Management, LLC
891.86K
8.75%
+79.18K
+9.74%
Sep 30, 2025
AWM Investment Company, Inc.
619.57K
6.08%
-300.00
-0.05%
Sep 30, 2025
The Vanguard Group, Inc.
278.58K
2.73%
+250.69K
+898.94%
Sep 30, 2025
Diadema Partners LP
272.67K
2.68%
+272.67K
--
Sep 30, 2025
Disbrow (Joshua R.)
207.20K
2.03%
+53.95K
+35.20%
Oct 13, 2025
Lytton (Laurence W)
122.06K
1.2%
-384.54K
-75.91%
Sep 30, 2025
Two Sigma Investments, LP
108.54K
1.07%
+73.50K
+209.79%
Sep 30, 2025
Renaissance Technologies LLC
95.12K
0.93%
+5.21K
+5.79%
Sep 30, 2025
Geode Capital Management, L.L.C.
71.01K
0.7%
+17.14K
+31.81%
Sep 30, 2025
查看更多
持股ETF
更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
Dimensional US Core Equity 1 ETF
0%
DFA Dimensional US Sustainability Core 1 ETF
0%
Dimensional US Core Equity 1 ETF
占比0%
DFA Dimensional US Sustainability Core 1 ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
除权除息日
类型
比率
Jan 05, 2023
Merger
20→1
Jan 05, 2023
Merger
20→1
Jan 05, 2023
Merger
20→1
Jan 05, 2023
Merger
20→1
Dec 08, 2020
Merger
10→1
Dec 08, 2020
Merger
10→1
公告日期
除权除息日
类型
比率
Jan 05, 2023
Merger
20→1
Jan 05, 2023
Merger
20→1
Jan 05, 2023
Merger
20→1
Jan 05, 2023
Merger
20→1
Dec 08, 2020
Merger
10→1
Dec 08, 2020
Merger
10→1
Dec 08, 2020
Merger
10→1
Dec 08, 2020
Merger
10→1
